SILODYX

This brand name is authorized in Austria, Croatia, Estonia, France, Ireland, Italy, Lithuania, Netherlands, Poland, South Africa, Spain, Turkey.

Active ingredients

The drug SILODYX contains one active pharmaceutical ingredient (API):

1	Silodosin UNII CUZ39LUY82 - SILODOSIN
	Silodosin is highly selective for α1A-adrenoreceptors that are primarily located in the human prostate, bladder base, bladder neck, prostatic capsule and prostatic urethra. Blockade of these α1A-adrenoreceptors causes smooth muscle in these tissues to relax, thus decreasing bladder outlet resistance, without affecting detrusor smooth muscle contractility.
	Read more about Silodosin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SILODYX Hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04CA04	Silodosin	G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CA Alpha-adrenoreceptor antagonists
Discover more medicines within G04CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1459403, 1459414, 1459425, 1459436, 1459447, 1459458, 1459469, 1459470, 1459481, 1459492, 1459504, 1459515, 1459526, 1459537
ES	Centro de información online de medicamentos de la AEMPS	09607004, 09607004IP, 09607011, 09607011IP, 09607011IP1, 09607011IP2, 09607011IP3
FR	Base de données publique des médicaments	61605245, 63911098
IT	Agenzia del Farmaco	039775046, 039775111
LT	Valstybinė vaistų kontrolės tarnyba	1053012, 1053013, 1053014, 1053015, 1053016, 1053017, 1053018, 1053019, 1053020, 1053021, 1053022, 1053023, 1053024, 1053025
NL	Z-Index G-Standaard, PRK	97276, 97284
PL	Rejestru Produktów Leczniczych	100316390, 100316409
TR	İlaç ve Tıbbi Cihaz Kurumu	8699960580015, 8699960580022
ZA	Health Products Regulatory Authority	45/34/0118, 45/34/0119